Common use of Consolidated Adjusted EBITDA Clause in Contracts

Consolidated Adjusted EBITDA. The Consolidated Adjusted EBITDA, as of the last day of each Test Period set forth below, to be less than the amount set forth below opposite such measurement date: Test Period Consolidated Adjusted EBITDA 4 quarters ending March 31, 2022 $10,500,000 4 quarters ending June 30, 2022 $11,000,000 4 quarters ending September 30, 2022 $13,000,000 4 quarters ending December 31, 2022 and each fiscal quarter thereafter $14,500,000

Consolidated Adjusted EBITDA. The Consolidated Adjusted EBITDA, as of the last day of each Test Period set forth below, to be less than the amount set forth below opposite such measurement date: Test Period Consolidated Adjusted EBITDA 4 quarters Quarters ending September 30, 2019 $ 2,000,000 4 Quarters ending December 31, 2019 $ 4,000,000 4 Quarters ending March 31, 2022 $10,500,000 2020 $ 8,000,000 4 quarters Quarters ending June 30, 2022 $11,000,000 2020 $ 14,000,000 4 quarters Quarters ending September 30, 2022 $13,000,000 4 quarters ending December 31, 2022 and each fiscal quarter thereafter $14,500,0002020 $ 18,000,000

Consolidated Adjusted EBITDA. The Consolidated Adjusted EBITDA, as of the last day of each Test Period set forth below, to be less than the amount set forth below opposite such measurement date: Test Period Consolidated Adjusted EBITDA 4 quarters ending March 31, 2021 $10,000,000 4 quarters ending June 30, 2021 $10,000,000 4 quarters ending September 30, 2021 $10,500,000 4 quarters ending December 31, 2021 $10,500,000 4 quarters ending March 31, 2022 $10,500,000 4 quarters ending June 30, 2022 $11,000,000 4 quarters ending September 30, 2022 $13,000,000 4 quarters ending December 31, 2022 and each fiscal quarter thereafter $14,500,00013,000,000

Consolidated Adjusted EBITDA. The Consolidated Adjusted EBITDA, as of the last day of each Test Period set forth below, to be less than the amount set forth below opposite such measurement date: date Test Period Consolidated Adjusted EBITDA 4 quarters ending June 30, 2021 $ (3,122,500 ) 4 quarters ending September 30, 2021 $ 10,500,000 4 quarters ending December 31, 2021 $ 10,500,000 4 quarters ending March 31, 2022 $$ 10,500,000 4 quarters ending June 30, 2022 $$ 11,000,000 4 quarters ending September 30, 2022 $13,000,000 4 quarters ending December 31, 2022 and each fiscal quarter thereafter $14,500,000$ 13,000,000

Consolidated Adjusted EBITDA. The Consolidated Adjusted EBITDA, as of the last day of each Test Period set forth below, to be less than the amount set forth below opposite such measurement date: Test Period Consolidated Adjusted EBITDA 4 quarters ending March 31, 2021 $10,000,000 4 quarters ending June 30, 2021 $10,000,000 4 quarters ending September 30, 2021 $10,500,000 4 quarters ending December 31, 2021 $10,500,000 4 quarters ending March 31, 2022 $10,500,000 4 quarters ending June 30, 2022 $11,000,000 4 quarters ending September 30, 2022 $13,000,000 4 quarters ending December 31, 2022 and each fiscal quarter thereafter $14,500,000

Consolidated Adjusted EBITDA. The Consolidated Adjusted EBITDA, as of the last day of each Test Period set forth below, to be less than the amount set forth below opposite such measurement date: Test Period Consolidated Adjusted EBITDA 4 quarters Quarters ending September 30, 2019 $ 3,000,000 4 Quarters ending December 31, 2019 $ 5,000,000 4 Quarters ending March 31, 2022 $10,500,000 2020 $ 10,000,000 4 quarters Quarters ending June 30, 2022 $11,000,000 2020 $ 16,000,000 4 quarters Quarters ending September 30, 2022 $13,000,000 4 quarters ending December 31, 2022 and each fiscal quarter thereafter $14,500,0002020 $ 20,000,000

Consolidated Adjusted EBITDA. The Consolidated Adjusted EBITDA, as of the last day of each Test Period set forth below, to be less than the amount set forth below opposite such measurement date: date Test Period Consolidated Adjusted EBITDA 4 quarters ending March 31, 2022 $10,500,000 4 quarters ending June 30, 2022 $11,000,000 4 quarters ending September 30, 2022 $13,000,000 4 quarters ending December 31, 2022 and each fiscal quarter thereafter $14,500,00013,000,000

Consolidated Adjusted EBITDA. The Consolidated Adjusted EBITDA, as of the last day of each Test Period set forth below, to be less than the amount set forth below opposite such measurement date: Test Period Consolidated Adjusted EBITDA 4 quarters ending June 30, 2021 $ (3,122,500 ) 4 quarters ending September 30, 2021 $ 10,500,000 4 quarters ending December 31, 2021 $ 10,500,000 4 quarters ending March 31, 2022 $$ 10,500,000 4 quarters ending June 30, 2022 $$ 11,000,000 4 quarters ending September 30, 2022 $$ 13,000,000 4 quarters ending December 31, 2022 and each fiscal quarter thereafter $$ 14,500,000